Survey on safety of medicines and reporting of adverse drug effects
European Medicines Agency (EMA) is currently conducting a survey on patients' and healthcare professionals' views on reporting of adverse drug reactions.
The survey is available in official EU languages and is open for responses until 9 October 2017.
The results will be analysed by EMA and a report provided to the European Commission.